Search Results - Driessen, Emma M. C.

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Identification of genes transcriptionally responsive to the loss of MLL fusions in MLL-rearranged acute lymphoblastic leukemia

    Identification of genes transcriptionally responsive to the loss of MLL fusions in MLL-rearranged acute lymphoblastic leukemia by van der Linden, Marieke H, Seslija, Lidija, Schneider, Pauline, Driessen, Emma M C, Castro, Patricia Garrido, Stumpel, Dominique J P M, van Roon, Eddy, de Boer, Jasper, Williams, Owen, Pieters, Rob, Stam, Ronald W

    Published in PloS one
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    CBL mutations do not frequently occur in paediatric acute myeloid leukaemia

    CBL mutations do not frequently occur in paediatric acute myeloid leukaemia by Coenen, Eva A., Driessen, Emma M. C., Zwaan, C.Michel, Stary, Jan, Baruchel, Andre, de Haas, Valerie, de Bont, Eveline S. J. M., Reinhardt, Dirk, Kaspers, Gertjan J. L., Arentsen-Peters, Susan T. C. J. M., Meyer, Claus, Marschalek, Rolf, Pieters, Rob, Stam, Ronald W., van den Heuvel-Eibrink, Marry M.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants

    Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants by Driessen, E. M. C., van Roon, E. H. J., Spijkers-Hagelstein, J. A. P., Schneider, P., de Lorenzo, P., Valsecchi, M. G., Pieters, R., Stam, R. W.

    Published in Haematologica (Roma)
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations

    MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations by Kerstjens, Mark, Driessen, Emma M C, Willekes, Merel, Pinhanços, Sandra S, Schneider, Pauline, Pieters, Rob, Stam, Ronald W

    Published in Oncotarget
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Versican expression is an adverse prognostic factor in MLL- rearranged infant acute lymphoblastic leukaemia

    Versican expression is an adverse prognostic factor in MLL- rearranged infant acute lymphoblastic leukaemia by Driessen, Emma M.C, Pinhanços, Sandra S. Mimoso, Schneider, Pauline, de Lorenzo, Paola, Valsecchi, Maria G, Pieters, Rob, Stam, Ronald W

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    MEK Inhibition Is a Promising Therapeutic Strategy for MLL-Rearranged Infant ALL Patients Carrying RAS Mutations

    MEK Inhibition Is a Promising Therapeutic Strategy for MLL-Rearranged Infant ALL Patients Carrying RAS Mutations by Kerstjens, Mark JB, Driessen, Emma MC, Willekes, Merel, Mimoso Pinhancos, Sandra S, Pieters, Rob, Stam, Ronald

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Identification of Genes Transcriptionally Responsive to the Loss of MLL Fusions in MLL-Rearranged Acute Lymphoblastic Leukemia: e0120326

    Identification of Genes Transcriptionally Responsive to the Loss of MLL Fusions in MLL-Rearranged Acute Lymphoblastic Leukemia: e0120326 by Linden, H vander, Seslija, Lidija, Schneider, Pauline, Driessen, Emma MC, Castro, Patricia Garrido, Stumpel, J PM, Roon, Eddy van, Boer, Jasper de, Williams, Owen, Pieters, Rob

    Published in PloS one
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: